Document Detail

Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis.
MedLine Citation:
PMID:  22166568     Owner:  NLM     Status:  MEDLINE    
MATERIAL AND METHODS: With the aim of analyzing the influence of presence of cirrhosis at baseline on the outcome, we revised the evolution of a cohort of patients with type 1 autoimmune hepatitis, prospectively followed at a single hospital. 139 patients (113 females, 26 males), median age 45.7 years, interquartile range 13-59 years, were followed-up for a median period of 58 months (interquartile range 27-106).
RESULTS: At baseline, 55 patients had cirrhosis and they were significantly older, had lower prothrombin activity and serum albumin than patients without cirrhosis. In contrast, patients without cirrhosis had significantly higher bilirubin, AST and ALT levels at diagnosis time. There was no significant difference in the follow-up time between patients with and without cirrhosis at baseline and either in the percentage of patients receiving immunosupresor treatment (80 vs. 91%, respectively) or in the response to therapy (complete response in 82 vs. 95%, respectively). However, patients with cirrhosis had a significantly lower probability of remaining free of cirrhosis complications (49.1% at 102 months, 95%CI, 35.5-67.9% vs. 86.7%, 95%CI, 77.1%-97.5%, respectively) (p = 0.0000) and a significantly lower overall survival at 120 months (67.1%, 95%CI, 51.3-87.6 vs. 94.4%, 95%CI, 86.9-100%, respectively) (p = 0.003) than those without cirrhosis at presentation.
CONCLUSION: Patients with type 1 autoimmune hepatitis and cirrhosis at presentation have a lower survival than those without cirrhosis despite a similar response to treatment.
Graciela Landeira; Silvia Morise; Eduardo Fassio; Margarita Ramonet; Estela Alvarez; Patricia Caglio; Cristina Longo; Nora Domínguez
Related Documents :
21880458 - Total vs hemi-aortic arch transposition for hybrid aortic arch repair.
22210988 - Comparison of the original and reduced versions of the berg balance scale and the weste...
20713278 - Instrumented bone preserving elbow prosthesis in rheumatoid arthritis: 2-8 year follow-up.
22176878 - Cost impact of extension cuff utilization during endovascular aneurysm repair.
16721618 - Pre- versus postoperative intraarticular application of local anesthetics and opioids v...
21713078 - Epidemiology of therapy-related myeloid neoplasms after treatment for pediatric acute l...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of hepatology     Volume:  11     ISSN:  1665-2681     ISO Abbreviation:  Ann Hepatol     Publication Date:    2012 Jan-Feb
Date Detail:
Created Date:  2011-12-14     Completed Date:  2012-06-12     Revised Date:  2013-05-16    
Medline Journal Info:
Nlm Unique ID:  101155885     Medline TA:  Ann Hepatol     Country:  Mexico    
Other Details:
Languages:  eng     Pagination:  100-6     Citation Subset:  IM    
Liver Unit, Hospital Nacional Profesor Alejandro Posadas, El Palomar, Provincia de Buenos Aires, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cohort Studies
Disease Progression
Follow-Up Studies
Hepatitis, Autoimmune / drug therapy*,  mortality*
Immunosuppressive Agents / therapeutic use*
Liver / pathology
Liver Cirrhosis / complications*,  pathology
Middle Aged
Prospective Studies
Retrospective Studies
Survival Rate
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy.
Next Document:  Amoebic liver abscess production by Entamoeba dispar.